Copyright
©The Author(s) 2024.
World J Gastrointest Surg. Jun 27, 2024; 16(6): 1803-1824
Published online Jun 27, 2024. doi: 10.4240/wjgs.v16.i6.1803
Published online Jun 27, 2024. doi: 10.4240/wjgs.v16.i6.1803
Figure 5 Visualization of functional enrichment (Gene Ontology) and pathway enrichment (Kyoto Encyclopedia of Genes and Genomes) analyses outcomes.
A: Histogram of functional enrichment [Gene Ontology (GO)] and pathway enrichment [Kyoto Encyclopedia of Genes and Genomes (KEGG)] analyses outcomes; B: Ring network of functional enrichment (GO) and pathway enrichment (KEGG) analyses outcomes; C: Circle plot of the combined logFC outcomes of functional enrichment (GO) and pathway enrichment (KEGG) analyses; D: String plot of the combined logFC outcomes of functional enrichment (GO) and pathway enrichment (KEGG) analyses. STAD: Stomach adenocarcinoma. GO: Gene Ontology; KEGG: Kyoto Encyclopedia of Genes and Genomes; BP: Biological process; CC: Bellular component; MF: Molecular function; Up: Up-regulated genes; Down: Down-regulated genes.
- Citation: Xie XZ, Zuo L, Huang W, Fan QM, Weng YY, Yao WD, Jiang JL, Jin JQ. FDX1 as a novel biomarker and treatment target for stomach adenocarcinoma. World J Gastrointest Surg 2024; 16(6): 1803-1824
- URL: https://www.wjgnet.com/1948-9366/full/v16/i6/1803.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v16.i6.1803